How Much Indole 3 Carbinol Should I Take A Day?

Indole-3-carbinol (I3C) powder has become increasingly popular in recent years as a dietary supplement purported to offer various health benefits. I3C is a naturally occurring compound found in cruciferous vegetables like broccoli, cabbage, and cauliflower. Understanding the appropriate dosage is important to maximize potential benefits while avoiding possible side effects. This article provides an overview of I3C, factors that may impact the ideal dosage, safety precautions, and general dosage recommendations based on available research.

 

Definition and Explanation 

Indole-3-carbinol is a phytochemical produced naturally in cruciferous vegetables like broccoli, cabbage, brussels sprouts and kale. When the plant's cell walls are broken down during chewing or chopping, an enzyme called myrosinase converts glucobrassicin to indole-3-carbinol (I3C).

I3C has been studied for its potential health benefits, particularly for supporting hormone balance in both men and women. Some research suggests it may have anti-disease effects by promoting natural detoxification processes in the body. I3C is also being investigated for potential benefits for conditions like fibromyalgia.

 

Forms and Availability 

I3C is found naturally in cruciferous vegetables, but the amount can vary widely depending on factors like plant maturity and storage conditions after harvest. As a result, supplements are popular for getting a consistent, standardized dose.

Supplements containing I3C are widely available in capsule, tablet and liquid extract forms. The most common supplemental forms are DIM (diindolylmethane) and I3C. DIM is the main conversion product when I3C is metabolized in the body.

 

The Recommended Dosage of Indole-3-Carbinol 

 

Lack of Official Recommended Daily Allowance

Currently there is no official recommended daily allowance (RDA) or daily value established for I3C. Unlike essential vitamins and minerals, regulatory bodies like the FDA and European Food Safety Authority (EFSA) have not set formal guidelines for Indole 3 Carbinol Powder intake. This is likely due to the lack of extensive research on the effects of regular I3C supplementation in humans.

Establishing a standardized dosage poses challenges due to the many variables that can impact optimal I3C intake, including differences in age, health status, formulation used, and desired health outcomes. The adequate amount for each individual may vary considerably.

 

General Guidelines from Experts and Studies

Though official recommendations are lacking, some general dosage suggestions have emerged based on preliminary research and anecdotal evidence. Most studies have used dosages between 200-400 mg per day for adults. However, amounts up to 800 mg daily have been used in some trials focused on breast health.

Some functional medicine practitioners recommend 100-300 mg of I3C or DIM for general health maintenance. Higher end of dosing ranges may be suggested therapeutically for hormone balance, metabolism or breast support. Intakes above 800 mg are not recommended without medical supervision.

For men, doses of 200-400 mg I3C or around 60-120 mg DIM are often suggested, but optimal intakes are still being established through research.

 

Factors to Consider When Determining the Dosage 

 

Individual Differences and Health Conditions

There are several factors that impact how much I3C an individual may require to obtain potential benefits. Age, health status, genetics, and specific health goals can all influence the ideal dosage.

For example, some research indicates that metabolism of I3C is slower in those with certain genetic variations affecting detoxification capacity. In these cases, smaller doses may be advised. Having underlying health conditions or taking medications may also warrant a more tailored approach to I3C supplementation.

Due to the potential for estrogen-driven tumor growth, Indole 3 Carbinol Powder is not recommended for those with hormonally-influenced diseases like breast or ovarian without medical guidance.

 

Quality and Formulation of I3C Supplements

The source, quality and formulation of I3C supplements can vary considerably between brands. Products may contain differing concentrations of I3C, ranging from 10 percent up to 99 percent. The structure utilized, for example, Faint or I3C, likewise influences the bioavailability and physiologic impacts.

While looking at supplements, following the measurements and suggestions of the particular manufacturer is significant. The required dose can differ greatly between a product standardized to just 10 percent I3C versus one with a much higher concentration.

 

Safety Precautions and Potential Side Effects 

 

Generally Recognized as Safe (GRAS) Status

In 2021, I3C was conceded Commonly Perceived as Protected (GRAS) status by the FDA. This implies it is viewed as protected when utilized as per Great Assembling Practice (GMP) and at the suggested measurements. Most clinical examinations utilizing supplemental dosages of up to 400 mg every day do not detail critical antagonistic impacts.

 

Potential Side Effects and Interactions

While by and large all around endured, there is some proof that high portions or broadened utilization of Indole 3 Carbinol Powder enhancements might actually cause secondary effects in certain people. There have been sporadic reports of joint pain, nausea, diarrhea, and headaches.

There is also a hypothetical risk that in certain individuals, I3C supplementation could promote formation of goiter through impacting thyroid function. Those with thyroid disorders should exercise caution with regular I3C use.

 

Because of its effect on drug-utilizing proteins, I3C may likewise communicate with specific prescriptions like tamoxifen and a few antidepressants. Before taking a supplement, people who take prescription medications should talk to their doctor.

As research continues, the safety profile and potential for side effects with both short and long term I3C supplementation will become more clear. Monitoring personal response and seeking medical attention for any concerning reactions is advised.

 

The Bottom Line 

In outline, there is right now no authority suggested everyday recompense laid out for Indole 3 Carbinol Powder. In view of accessible exploration, measurements ranging between 200-400 mg day to day are in many cases proposed, however, the ideal sum for every individual can differ impressively founded on factors like age, hereditary qualities, and well-being status. It's vital to choose top-notch I3C supplements and follow the measurements proposals of the producer. While by and large very much endured, potential secondary effects are conceivable with high or delayed admissions. Counseling a proficient medical services professional gives the best way to deal with deciding the fitting I3C measurement with regard to your general well-being objectives and clinical history. Similarly as with any enhancement, integrating I3C as a component of a sound, adjusted way of life is encouraged.

 

Hongda Phytochemistry Co., Ltd. boasts an impressive array of Certifications, including cGMP, BRC, ORGANIC (EU), ORGANIC (NOP), ISO22000, ISO9001, FDA, HALAL, KOSHER, and national certification of high-tech innovative enterprises. With over 30 years of experience in ingredient manufacturing, the Shaanxi Hongda factory stands as a testament to our expertise. Spanning 20,000 square meters, the factory is equipped with advanced extraction equipment and houses our own SGS-certified laboratory. Operating six state-of-the-art production lines simultaneously, the facility achieves a daily output of ten tons and an annual yield of several thousand tons. For those interested in Indole 3 Carbinol Powder, inquiries can be directed to duke@hongdaherb.com.

 

References:

1,Bradlow,H.L., Michnovicz,J.J., Telang,N.T., & Osborne,M.P.( 1991). goods of salutary indole-3-carbinol on estradiol metabolism and robotic mammary excrescences in mice. Carcinogenesis, 12( 9), 1571 – 1574.

2,Brandi,G., Schiavano,G.F., Zaffaroni,N., De Marco,C., Paiardini,M., Cervasi,B., & Magnani,M.( 2005). Mechanisms of action and antiproliferative parcels of Brassica oleracea juice in mortal bone complaint cell lines. Journal of Nutrition, 135( 6), 1503- 1509.

3,Brayton,C.F.( 2017). DIM( diindolylmethane) Advantages as a preferential estrogen receptor beta agonist. Indispensable curatives In Health & Medicine, 23( 4), 36- 40.

4,Leibelt,D.A., Hedstrom,O.R., Fischer,K.A., Pereira,C.B., & Williams,K.E.( 2003). Evaluation of habitual salutary exposure to indole-3-carbinol and immersion- enhanced 3, 3 ′- diindolylmethane in sprague- dawley rats. Toxicological lores, 74( 1), 10- 21.

5,Reed,G.A., Sunega,J.M., Sullivan,D.K., Gray,J.C., Mayo,M.S., Crowell,J.A., & Hurwitz,A.( 2008). Single- cure pharmacokinetics and tolerability of immersion- enhanced 3, 3 ′- diindolylmethane in healthy subjects. complaint Epidemiology Biomarkers & Prevention, 17( 10), 2619- 2624.

6,Thomson,C.A., Chow,H.S., Wertheim,B.C., Roe,D.J., Stopeck,A., Maskarinec,G.,. & Cussler,E.( 2010). A randomized, placebo- controlled trial of diindolylmethane for bone complaint biomarker modulation in cases taking tamoxifen. bone complaint exploration and Treatment, 122( 1), 97- 107.

7,Wong,G.Y., Bradlow,L., Sepkovic,D., Mehl,S., Mailman,J., & Osborne,M.P.( 1997). Cure- ranging study of indole-3-carbinol for bone complaint forestallment. The Journal of Cellular Biochemistry. Supplement, 28- 29, 111- 116.

8,Yuan,F., Chen,D.Z., Liu,K., Sepkovic,D.W., Bradlow,H.L., & Auborn,K.( 1999). Anti-estrogenic conditioning of indole-3-carbinol in cervical cells recrimination for forestallment of cervical complaint. Antidisease Research, 19( 3A), 1673 – 1680.

9,Bradlow, H. L., Michnovicz, J. J., Halper, M., Mill operator, D. G., Wong, G. Y., and Osborne, M. P. (1994). Long haul reactions of ladies to indole-3-carbinol or a high fiber diet. Malignant growth The study of disease transmission and Counteraction Biomarkers, 3(7), 591-595.

10,K. M. Dalessandri, G. L. Firestone, M. D. Fitch, H. L. Bradlow, and L. F. Bjeldanes Pilot project: impact of 3, 3′-diindolylmethane supplements on urinary chemical metabolites in postmenopausal ladies with a background marked by beginning phase bosom malignant growth. Nourishment and disease, 50(2), 161-167.

11,Howells, L. M., Gallacher-Horley, B., Houghton, C. E., Manson, M. M., and Hudson, E. A. (2002). In the human breast tumor cell line MDA MB468, indole-3-carbinol induces apoptosis and inhibits protein kinase B/Akt, but not in the nontumorigenic HBL100 line. Atomic disease therapeutics, 1(13), 1161-1172.

12,Leong, H., Riby, J. E., Firestone, G. L., and Bjeldanes, L. F. (2001). Intense ligand-free estrogen receptor initiation by 3, 3′-diindolylmethane is interceded by cross talk between the protein kinase An and mitogen-enacted protein kinase flagging pathways. Sub-atomic endocrinology, 15(9), 1578-1589.

13,Meng, Q., Goldberg, I. D., Rosen, E. M., and Fan, S. (2000). Inhibitory impacts of Indole-3-carbinol on attack and movement in human bosom disease cells. Bosom malignant growth examination and treatment, 63(2), 147-152.

14,Rajoria, S., Suriano, R., Parmar, P. S., Wilson, Y. L., Megwalu, U., Moscatello, A., ... and Sepkovic, D. W. (2011). Thyroid proliferative disease patients' estrogen metabolism is influenced by 3, 3′-diindolylmethane: a pilot study. Thyroid, 21(3), 299-304.

15,Reed, G. A., Peterson, K. S., Smith, H. J., Dim, J. C., Sullivan, D. K., Mayo, M. S., ... and Hurley, T. G. (2005). A stage I investigation of indole-3-carbinol in ladies: bearableness and impacts. Disease the study of disease transmission biomarkers and avoidance, 14(8), 1953-1960.

16,Bjeldanes, L. F., Xue, J. E. Riby, U. Chatterji, E. L. Bjeldanes, G. L. Firestone, and Actuation and potentiation of interferon-gamma announcing 3, 3′-diindolylmethane in MCF-7 bosom disease cells. Atomic pharmacology, 69(3), 430-439.

17,Rosen, C. A., Woodson, G. E., Thompson, J. W., Hengesteg, A. P., and Bradlow, H. L. (1998). Fundamental aftereffects of the utilization of indole-3-carbinol for intermittent respiratory papillomatosis. Otolaryngology - Head and Neck A medical procedure, 118(6), 810-815.

18,Sepkovic, D. W., Bradlow, H. L., Michnovicz, J., Murtezani, S., Toll, I., and Osborne, M. P. (1994). Following treatment with indole-3-carbinol, ascorbigen, or -naphthoflavone, catechol estrogen production in rat microsomes: a comparison between radiometric and stable isotope dilution gas chromatography-mass spectrometry techniques. 318-323 in Steroids, 59(5).

19,Wong, G. Y., Bradlow, L., Sepkovic, D., Mehl, S., Postal worker, J., and Osborne, M. P. (1997). Indole-3-carbinol's dose-ranging study for breast disease prevention. The Diary of Cell Organic chemistry, 28S, 111-116.